. 2016 Sep 21;2016:3121402. doi: 10.1155/2016/3121402

Table 2.

Comparison of immune function indices and cytokines in the treatment and control groups before and after treatment (x ± s).

Variable	Treatment group (n = 167)		Control group (n = 165)
Variable	Before treatment	After treatment	Before treatment	After treatment
CD3+	56.43 ± 4.22	55.45 ± 4.22^∗a	55.38 ± 5.33	34.29 ± 4.93^b
CD4+	31.55 ± 5.33	35.35 ± 4.24^∗a	33.19 ± 5.39	17.13 ± 5.81^b
CD8+	13.32 ± 2.33	13.12 ± 2.23^∗	14.31 ± 3.02	15.23 ± 3.03^b
CD4+/CD8+	1.69 ± 0.33	1.73 ± 0.22^∗	1.68 ± 0.42	1.08 ± 0.33^b
NK cells	15.44 ± 3.35	15.41 ± 4.02^∗	15.12 ± 3.72	10.12 ± 3.11^b
IgG	12.5 ± 1.3	12.3 ± 1.2^∗	12.4 ± 1.3	7.2 ± 1.5^b
IgA	2.4 ± 0.3	2.3 ± 0.3^∗a	2.4 ± 0.3	1.2 ± 0.5^b
IgM	1.71 ± 0.30	1.58 ± 0.4^∗a	1.81 ± 0.47	0.45 ± 0.53^b
IL-4	20.0 ± 2.4	22.2 ± 2.3^∗a	22.5 ± 3.2	11.8 ± 2.2^b
IL-10	17.10 ± 2.2	19.4 ± 4.2^∗a	18.90 ± 2.1	9.80 ± 3.2^b

Notes: compared with the control group after treatment, ^∗ p < 0.05; compared with the treatment group before treatment, ^a p < 0.05; compared with the control group before treatment, ^b p < 0.05.